Payment overview · 2025
General Payments
$65.60
3 reported records · 2 companies
Healthcare provider profile · identity verified
Corey Stephan Macrander, MD
Allopathic & Osteopathic Physicians|Internal Medicine · APPLETON, WI · NPI 1346747755
Verified facts
What the public records show
CMS Open Payments records show Corey Stephan Macrander, MD received $65.60 in general payments during 2025 across 3 reported records.
SANOFI-AVENTIS U.S. LLC accounted for 73.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | Unresolved — no canonical attribution shown | $48.23 | 73.5% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $17.37 | 26.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $65.60 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TZIELD Normalized: tzield |
Biological | SANOFI-AVENTIS U.S. LLC | $48.23 | 2 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $17.37 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $17.37 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 913 | 228 |
| Amlodipine Besylate | Amlodipine Besylate | 753 | 193 |
| Lisinopril | Lisinopril | 542 | 136 |
| Losartan Potassium | Losartan Potassium | 535 | 133 |
| Levothyroxine Sodium | Levothyroxine Sodium | 472 | 108 |
| Omeprazole | Omeprazole | 445 | 117 |
| Metoprolol Succinate | Metoprolol Succinate | 407 | 93 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 402 | 111 |
| Hydrochlorothiazide | Hydrochlorothiazide | 342 | 91 |
| Simvastatin | Simvastatin | 310 | 81 |
| Warfarin Sodium | Warfarin Sodium | 263 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 256 | 78 |
| Metformin Hcl Er | Metformin Hcl | 244 | 61 |
| Metformin Hcl | Metformin Hcl | 227 | 56 |
| Gabapentin | Gabapentin | 223 | 46 |
| Metoprolol Tartrate | Metoprolol Tartrate | 219 | 55 |
| Furosemide | Furosemide | 210 | 57 |
| Pantoprazole Sodium | Pantoprazole Sodium | 194 | 55 |
| Eliquis | Apixaban | 192 | 48 |
| Carvedilol | Carvedilol | 174 | 40 |
| Allopurinol | Allopurinol | 160 | 42 |
| Escitalopram Oxalate | Escitalopram Oxalate | 160 | 37 |
| Duloxetine Hcl | Duloxetine Hcl | 145 | 35 |
| Alendronate Sodium | Alendronate Sodium | 138 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 134 | 27 |
| Jardiance | Empagliflozin | 129 | 28 |
| Sertraline Hcl | Sertraline Hcl | 127 | 28 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 126 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 125 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 118 | 51 |
| Glimepiride | Glimepiride | 116 | 28 |
| Finasteride | Finasteride | 113 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 113 | 37 |
| Trazodone Hcl | Trazodone Hcl | 112 | 29 |
| Doxazosin Mesylate | Doxazosin Mesylate | 110 | 28 |
| Ozempic | Semaglutide | 105 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 104 | 32 |
| Potassium Chloride | Potassium Chloride | 104 | 34 |
| Atenolol | Atenolol | 101 | 27 |
| Spironolactone | Spironolactone | 97 | 24 |
| Pregabalin | Pregabalin | 93 | 16 |
| Lorazepam | Lorazepam | 88 | 24 |
| Buspirone Hcl | Buspirone Hcl | 87 | 17 |
| Clonazepam | Clonazepam | 87 | 15 |
| Famotidine | Famotidine | 87 | 21 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 86 | 30 |
| Glipizide | Glipizide | 84 | 21 |
| Glipizide Er | Glipizide | 84 | 20 |
| Montelukast Sodium | Montelukast Sodium | 84 | 18 |
| Tramadol Hcl | Tramadol Hcl | 80 | 17 |
| Mirtazapine | Mirtazapine | 78 | 17 |
| Alprazolam | Alprazolam | 77 | 15 |
| Xarelto | Rivaroxaban | 77 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 77 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 73 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 70 | 19 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 69 | 17 |
| Synthroid | Levothyroxine Sodium | 68 | 20 |
| Cephalexin | Cephalexin | 66 | 45 |
| Citalopram Hbr | Citalopram Hydrobromide | 66 | 17 |
| Lovastatin | Lovastatin | 66 | 22 |
| Bupropion Xl | Bupropion Hcl | 62 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 62 | 14 |
| Chlorthalidone | Chlorthalidone | 60 | 17 |
| Memantine Hcl | Memantine Hcl | 60 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 56 | 49 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 55 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 54 | 42 |
| Temazepam | Temazepam | 54 | suppressed |
| Prednisone | Prednisone | 53 | 41 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 50 | 37 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 50 | 16 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 47 | 14 |
| Benazepril Hcl | Benazepril Hcl | 46 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 43 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 43 | 11 |
| Trulicity | Dulaglutide | 42 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 39 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 39 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 37 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 35 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 35 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 35 | suppressed |
| Ezetimibe | Ezetimibe | 32 | suppressed |
| Valsartan | Valsartan | 32 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 31 | 11 |
| Enalapril Maleate | Enalapril Maleate | 31 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 31 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 31 | suppressed |
| Gemfibrozil | Gemfibrozil | 30 | suppressed |
| Ketoconazole | Ketoconazole | 30 | 17 |
| Labetalol Hcl | Labetalol Hcl | 30 | suppressed |
| Nifedipine Er | Nifedipine | 30 | suppressed |
| Diazepam | Diazepam | 29 | suppressed |
| Amoxicillin | Amoxicillin | 28 | 19 |
| Donepezil Hcl | Donepezil Hcl | 28 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 27 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 27 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 27 | suppressed |
| Nitroglycerin | Nitroglycerin | 26 | 17 |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 25 | 25 |
| Testosterone | Testosterone | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Topiramate | Topiramate | 24 | suppressed |
| Estradiol | Estradiol | 23 | 12 |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Loperamide | Loperamide Hcl | 23 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Aripiprazole | Aripiprazole | 22 | suppressed |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 19 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 19 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Methylprednisolone | Methylprednisolone | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 18 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | 12 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 17 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 17 | suppressed |
| Mounjaro | Tirzepatide | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Azithromycin | Azithromycin | 16 | 15 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 16 | 16 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Klor-Con M20 | Potassium Chloride | 16 | suppressed |
| Lamotrigine | Lamotrigine | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Metolazone | Metolazone | 16 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 15 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Desloratadine | Desloratadine | 13 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Nystop | Nystatin | 13 | suppressed |
| Sucralfate | Sucralfate | 13 | suppressed |
| Amiloride Hcl | Amiloride Hcl | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 11 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $65.60 · 3 records | SANOFI-AVENTIS U.S. LLC | OTEZLA, REPATHA, TZIELD | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error